Search Results - "Bell, Jill A"

The prevalence of lower urinary tract symptoms (LUTS) and overactive bladder (OAB) by racial/ethnic group and age: Results from OAB-POLL by Coyne, Karin S., Sexton, Chris C., Bell, Jill A., Thompson, Christine L., Dmochowski, Roger, Bavendam, Tamara, Chen, Chieh-I, Quentin Clemens, J.

“…Aims To estimate the prevalence of LUTS and OAB in a large, ethnically diverse US study. Methods This cross‐sectional, population‐representative survey was…”
Get full text

Intramuscular lipid metabolism, insulin action, and obesity by Consitt, Leslie A., Bell, Jill A., Houmard, Joseph A.

“…With the increasing prevalence of obesity, research has focused on the molecular mechanism(s) linking obesity and skeletal muscle insulin resistance. Metabolic…”
Get full text

Identifying symptomatic adverse events using the patient‐reported outcomes version of the common terminology criteria for adverse events in patients with non‐small cell lung cancer with epidermal growth factor receptor exon 20 insertion mutations by Zhu, Yanyan, Jean‐Baptiste, Milenka, Lenderking, William R., Bell, Jill A., Revicki, Dennis A., Lin, Huamao M., Brake, Rachael, Reeve, Bryce B.

“…Objective Tolerability and safety of treatments are important in oncology trials and should be informed by patient assessments. We identified the most relevant…”
Get full text

Measuring patient-reported physical functioning and fatigue in myelodysplastic syndromes using a modular approach based on EORTC QLQ-C30 by Regnault, Antoine, Pompilus, Farrah, Ciesluk, Anna, Mazerolle, Flora, Bejar, Rafael, Fram, Robert J., Faller, Douglas V., Marquis, Patrick, Bell, Jill A.

“…Purpose Physical functioning and fatigue are key patient concerns in myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid…”
Get full text

Basal muscle intracellular amino acid kinetics in women and men by Fujita, Satoshi, Rasmussen, Blake B, Bell, Jill A, Cadenas, Jerson G, Volpi, Elena

“…Sexual dimorphism in skeletal muscle mass is apparent, with men having more muscle mass and larger individual muscle cells. However, no sex-based differences…”
Get more information

A pragmatic patient-reported outcome strategy for rare disease clinical trials: application of the EORTC item library to myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia by Bell, Jill A., Galaznik, Aaron, Pompilus, Farrah, Strzok, Sara, Bejar, Rafael, Scipione, Fatima, Fram, Robert J., Faller, Douglas V., Cano, Stefan, Marquis, Patrick

“…Background Novel, pragmatic, patient-centered strategies are needed to ensure fit-for-purpose patient-reported outcomes (PRO) instruments in clinical trial…”
Get full text

Economic Burden of Patients Treated for Higher-Risk Myelodysplastic Syndromes (HR-MDS) in Routine Clinical Care in the United States by Bell, Jill A., Galaznik, Aaron, Blazer, Marlo, Shih, Huai-Che, Farrelly, Eileen, Ogbonnaya, Augustina, Eaddy, Michael, Fram, Robert J., Faller, Douglas V.

“…Background and Objective Significant clinical burden is associated with higher-risk myelodysplastic syndromes (HR-MDS); however, the economic burden has not…”
Get full text

Gastrointestinal adverse events with combination of checkpoint inhibitors in advanced melanoma: a systematic review by Mearns, Elizabeth S, Bell, Jill A, Galaznik, Aaron, Puglielli, Stefanie M, Cichewicz, Allie B, Boulanger, Talia, Garcia-Ribas, Ignacio

“…Immunotherapies, including checkpoint inhibitors (CIs) such as cytotoxic T-lymphocyte antigen-4 (CTLA-4) and programmed death-1 (PD-1) inhibitors, are…”
Get full text

Patient‐Reported Factors in Treatment Satisfaction in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) by Chari, Ajai, Romanus, Dorothy, DasMahapatra, Pronabesh, Hoole, Michael, Lowe, Maria, Curran, Chris, Campbell, Scott, Bell, Jill A.

“…Background Therapy choices in relapsed/refractory multiple myeloma (RRMM) should consider patient satisfaction with treatment, because it is associated with…”
Get full text

Evaluation of treatment patterns and survival among patients with diffuse large B-cell lymphoma in the USA by Morrison, Vicki A, Shou, Yaping, Bell, Jill A, Hamilton, Laurie, Ogbonnaya, Augustina, Raju, Aditya, Hennenfent, Kristin, Eaddy, Michael, Galaznik, Aaron

“…To evaluate treatment patterns of diffuse large B-cell lymphoma (DLBCL). First-line and relapsed/refractory treatment patterns and survival outcomes following…”
Get full text

The Co-occurrence of Reading Disorder and ADHD: Epidemiology, Treatment, Psychosocial Impact, and Economic Burden by Sexton, Chris C., Gelhorn, Heather L., Bell, Jill A., Classi, Peter M.

“…The co-occurrence of reading disorder (RD) and attention-deficit/hyperactivity disorder (ADHD) has received increasing attention. This review summarizes the…”
Get full text

Economic burden of patients with diffuse large B-cell and follicular lymphoma treated in the USA by Morrison, Vicki A, Bell, Jill A, Hamilton, Laurie, Ogbonnaya, Augustina, Shih, Huai-Che, Hennenfent, Kristin, Eaddy, Michael, Shou, Yaping, Galaznik, Aaron

“…Evaluate healthcare costs and utilization of treated diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL) patients. Adults with newly diagnosed…”
Get full text

Economic burden of elderly patients with acute myeloid leukemia treated in routine clinical care in the United States by Bell, Jill A., Galaznik, Aaron, Farrelly, Eileen, Blazer, Marlo, Murty, Sharanya, Ogbonnaya, Augustina, Eaddy, Michael, Fram, Robert J., Faller, Douglas V., Kota, Vamsi

“…[Display omitted] •Healthcare utilization in elderly acute myeloid leukemia patients is substantial.•92% of our population had ≥1 hospital admission over the…”
Get full text

Treatment Patterns and Survival Outcomes in Patients With Follicular Lymphoma: A 2007 to 2015 Humedica Database Study by Morrison, Vicki A., Shou, Yaping, Bell, Jill A., Hamilton, Laurie, Ogbonnaya, Augustina, Raju, Aditya, Hennenfent, Kristin, Eaddy, Michael, Galaznik, Aaron

“…Few studies have evaluated real-world treatment patterns and survival in follicular lymphoma (FL). This study evaluated these outcomes among newly diagnosed…”
Get full text

What Do We Know about Asthma Triggers? A Review of the Literature by Vernon, Margaret K., Wiklund, Ingela, Bell, Jill A., Dale, Peter, Chapman, Kenneth R.

“…Objective. For patients with asthma, exacerbations and poor control can result from exposure to environmental triggers, such as allergens and air particulates…”
Get full text

A retrospective study evaluating treatment patterns and survival outcomes in elderly patients with acute myeloid leukemia treated in the United States with either 7+3 or a hypomethylating agent by Bell, Jill A., Galaznik, Aaron, Farrelly, Eileen, Blazer, Marlo, Murty, Sharanya, Ogbonnaya, Augustina, Eaddy, Michael, Fram, Robert J., Faller, Douglas V., Kota, Vamsi K.

“…•More elderly acute myeloid leukemia patients used more intensive induction therapy.•Patients with less intensive induction therapy were older with more…”
Get full text

Use of the SF-36v2 Health Survey as a Screen for Risk of Major Depressive Disorder in a US Population-based Sample and Subgroup With Chronic Pain by Bell, Jill A., DiBonaventura, Marco daCosta, Witt, Edward A., Ben-Joseph, Rami, Reeve, Bryce B.

“…STUDY OBJECTIVES:To assess the feasibility of using the SF-36v2 mental health (MH) and mental component summary (MCS) scores for classification of risk for…”
Get full text

Systematic Literature Review of Treatment Options and Clinical Outcomes for Patients With Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia by Bell, Jill A., Galaznik, Aaron, Huelin, Rachel, Stokes, Michael, Guo, Yelan, Fram, Robert J., Faller, Douglas V.

“…High-dose chemotherapy with allogeneic hematopoietic stem cell transplantation (allo-HSCT) can produce long-term remission in patients with higher-risk…”
Get full text

Transfusion-free interval is associated with improved survival in patients with higher-risk myelodysplastic syndromes engaged in routine care by Bell, Jill A., Galaznik, Aaron, Blazer, Marlo, Farrelly, Eileen, Ogbonnaya, Augustina, Raju, Aditya, Eaddy, Michael, Fram, Robert J., Faller, Douglas V.

“…Most higher-risk myelodysplastic syndrome (HR-MDS) patients will become transfusion-dependent, leading to potential complications, including infections or…”
Get full text

Effectiveness and Safety of Therapeutic Regimens for Elderly Patients With Acute Myeloid Leukemia: A Systematic Literature Review by Bell, Jill A., Galaznik, Aaron, Huelin, Rachel, Stokes, Michael, Guo, Yelan, Fram, Robert J., Faller, Douglas V.

“…Acute myeloid leukemia (AML) is the second most common leukemia among adults. Although the median age at diagnosis is 67 years, with approximately one third of…”
Get full text